{"hands_on_practices": [{"introduction": "The functional properties of the glial scar are largely dictated by the composition of its extracellular matrix. This exercise provides a hands-on approach to modeling the biochemical makeup of the scar by integrating the secretory contributions of its diverse cellular inhabitants and the dynamics of matrix turnover. By applying principles of steady-state kinetics, you will calculate the relative abundance of inhibitory chondroitin sulfate proteoglycans (CSPGs) versus fibrotic collagens, providing a quantitative link between cellular activity and tissue-level properties. [@problem_id:2744743]", "problem": "In a stabilized spinal cord injury scar border at subacute time, stereological counts indicate the following cell-type composition by fraction of total cells: astrocytes $0.40$, perivascular fibroblasts $0.30$, neuron-glial antigen 2 (NG2) glia, also called oligodendrocyte precursor cells (OPCs), $0.20$, and microglia $0.10$. Consider two extracellular matrix classes central to reactive astrogliosis and glial scarring: chondroitin sulfate proteoglycans (CSPGs) and fibrillar collagens. Assume each cell type secretes each macromolecule at a constant per-cell rate (in $\\mathrm{pg \\cdot cell^{-1} \\cdot day^{-1}}$), and each macromolecule undergoes first-order degradation with a constant rate (in $\\mathrm{day^{-1}}$) due to matrix metalloproteinase activity. Specifically, take the per-cell secretion rates to be:\n- CSPG: astrocyte $1.2$, perivascular fibroblast $0.05$, NG2 glia $0.60$, microglia $0$.\n- Collagen: astrocyte $0.20$, perivascular fibroblast $5.0$, NG2 glia $0.10$, microglia $0$.\nLet the first-order degradation rate constants be $k_{\\mathrm{CSPG}} = 0.35$ and $k_{\\mathrm{coll}} = 0.10$. Assume the scar border is at steady state in which net macromolecule accumulation rates are zero, total tissue volume is fixed, and cellular secretion contributions sum linearly.\n\nUsing only conservation of mass and first-order kinetics, derive from first principles the expression for the steady-state CSPG-to-collagen mass ratio in the scar border and compute its numerical value based on the data above. Express your final answer as a single dimensionless number and round to three significant figures.", "solution": "The goal is to compute the steady-state ratio of chondroitin sulfate proteoglycan (CSPG) mass to collagen mass within the scar border. The appropriate starting point is mass balance for each macromolecule under constant production and first-order degradation. For any macromolecule $X$ (either CSPG or collagen), let $M_{X}(t)$ denote its mass within the considered volume. The mass balance is\n$$\n\\frac{d M_{X}}{d t} = P_{X} - k_{X} M_{X},\n$$\nwhere $P_{X}$ is the total production rate (mass per unit time) summed over cell types, and $k_{X}$ is the first-order degradation rate constant.\n\nAt steady state, there is no net accumulation, so $\\frac{d M_{X}}{d t} = 0$, which gives\n$$\n0 = P_{X} - k_{X} M_{X} \\quad \\Longrightarrow \\quad M_{X} = \\frac{P_{X}}{k_{X}}.\n$$\nThe production rate $P_{X}$ arises from the sum of per-cell secretion rates across cell types multiplied by their abundances. Let $N$ be the total number of cells in the volume, and let $f_{i}$ be the fraction of cells that are of type $i$, so that the abundance of type $i$ is $N f_{i}$. Let $r_{i,X}$ be the per-cell secretion rate of macromolecule $X$ for cell type $i$. Then the total production rate is\n$$\nP_{X} = \\sum_{i} (N f_{i}) r_{i,X} = N \\sum_{i} f_{i} r_{i,X}.\n$$\nTherefore, the steady-state mass of $X$ is\n$$\nM_{X} = \\frac{N \\sum_{i} f_{i} r_{i,X}}{k_{X}}.\n$$\nThe CSPG-to-collagen mass ratio $R$ at steady state is\n$$\nR \\equiv \\frac{M_{\\mathrm{CSPG}}}{M_{\\mathrm{coll}}} = \\frac{\\dfrac{N \\sum_{i} f_{i} r_{i,\\mathrm{CSPG}}}{k_{\\mathrm{CSPG}}}}{\\dfrac{N \\sum_{i} f_{i} r_{i,\\mathrm{coll}}}{k_{\\mathrm{coll}}}} = \\frac{k_{\\mathrm{coll}}}{k_{\\mathrm{CSPG}}} \\cdot \\frac{\\sum_{i} f_{i} r_{i,\\mathrm{CSPG}}}{\\sum_{i} f_{i} r_{i,\\mathrm{coll}}},\n$$\nwhere $N$ cancels, demonstrating that the ratio is independent of the absolute cell number and tissue volume under the stated assumptions.\n\nNext, we compute the production-weighted sums using the given fractions and per-cell secretion rates. Denote the four cell types by $i \\in \\{\\text{astrocyte}, \\text{fibroblast}, \\text{NG2 glia}, \\text{microglia}\\}$ with fractions\n$$\nf_{\\text{astro}} = 0.40, \\quad f_{\\text{fibro}} = 0.30, \\quad f_{\\text{NG2}} = 0.20, \\quad f_{\\text{micro}} = 0.10.\n$$\nCSPG per-cell rates (in $\\mathrm{pg \\cdot cell^{-1} \\cdot day^{-1}}$) are\n$$\nr_{\\text{astro},\\mathrm{CSPG}} = 1.2, \\quad r_{\\text{fibro},\\mathrm{CSPG}} = 0.05, \\quad r_{\\text{NG2},\\mathrm{CSPG}} = 0.60, \\quad r_{\\text{micro},\\mathrm{CSPG}} = 0.\n$$\nCollagen per-cell rates are\n$$\nr_{\\text{astro},\\mathrm{coll}} = 0.20, \\quad r_{\\text{fibro},\\mathrm{coll}} = 5.0, \\quad r_{\\text{NG2},\\mathrm{coll}} = 0.10, \\quad r_{\\text{micro},\\mathrm{coll}} = 0.\n$$\nForm the weighted sums:\n$$\n\\sum_{i} f_{i} r_{i,\\mathrm{CSPG}} = (0.40)(1.2) + (0.30)(0.05) + (0.20)(0.60) + (0.10)(0) = 0.48 + 0.015 + 0.12 + 0 = 0.615,\n$$\n$$\n\\sum_{i} f_{i} r_{i,\\mathrm{coll}} = (0.40)(0.20) + (0.30)(5.0) + (0.20)(0.10) + (0.10)(0) = 0.08 + 1.50 + 0.02 + 0 = 1.60.\n$$\nWith $k_{\\mathrm{CSPG}} = 0.35$ and $k_{\\mathrm{coll}} = 0.10$, we have\n$$\n\\frac{k_{\\mathrm{coll}}}{k_{\\mathrm{CSPG}}} = \\frac{0.10}{0.35} = \\frac{2}{7}.\n$$\nTherefore,\n$$\nR = \\frac{2}{7} \\cdot \\frac{0.615}{1.60} = \\frac{2 \\cdot 0.615}{7 \\cdot 1.60} = \\frac{1.23}{11.2} = \\frac{123}{1120} \\approx 0.109821\\ldots\n$$\nRounded to three significant figures, the dimensionless ratio is\n$$\nR \\approx 0.110.\n$$", "answer": "$$\\boxed{0.110}$$", "id": "2744743"}, {"introduction": "Beyond its molecular composition, the glial scar's dense and complex architecture creates a physical impediment to molecular transport. This practice introduces the biophysical concept of tortuosity, $\\lambda$, to quantify this impediment and explore its functional consequences. You will derive how diffusion time scales with tortuosity and calculate the impact of scar maturation on delaying molecular movement, a key aspect of its barrier function. [@problem_id:2744748]", "problem": "A focal Central Nervous System (CNS) lesion triggers reactive astrogliosis, leading to extracellular matrix remodeling and the formation of a glial scar with increased geometric hindrance to molecular motion in the extracellular space (ECS). Consider a small, nonbinding solute with free-solution diffusivity $D$ moving through a homogeneous scar slab of thickness $L$. In such porous media, the tortuosity $\\lambda$ is defined operationally via an effective diffusivity $D_{\\mathrm{eff}} = D / \\lambda^{2}$. For one-dimensional diffusion across a slab, the characteristic traversal time $t$ scales with the distance through the mean-square displacement relation $\\langle x^{2} \\rangle = 2 D_{\\mathrm{eff}} t$.\n\nA scar matures over time, and its tortuosity increases from $\\lambda_{1} = 1.6$ to $\\lambda_{2} = 2.0$. Take the slab thickness to be $L = 100\\,\\mu\\mathrm{m}$ and the soluteâ€™s free diffusivity to be $D = 6.0 \\times 10^{-10}\\,\\mathrm{m}^{2}\\,\\mathrm{s}^{-1}$. Starting strictly from the definitions above, derive how the characteristic diffusion time $t$ depends on $\\lambda$, and then compute the multiplicative factor by which $t$ changes when $\\lambda$ increases from $\\lambda_{1}$ to $\\lambda_{2}$. Express your final answer as a single dimensionless number. Do not round.", "solution": "The task is to first derive the dependence of the characteristic diffusion time, $t$, on the tortuosity, $\\lambda$, and then compute the multiplicative factor by which $t$ changes as $\\lambda$ increases from an initial value $\\lambda_{1}$ to a final value $\\lambda_{2}$.\n\nThe problem provides the following fundamental relations:\n1. The definition of effective diffusivity, $D_{\\mathrm{eff}}$, in terms of the free-solution diffusivity, $D$, and tortuosity, $\\lambda$:\n$$D_{\\mathrm{eff}} = \\frac{D}{\\lambda^{2}}$$\n2. The one-dimensional mean-square displacement relation for a particle diffusing with effective diffusivity $D_{\\mathrm{eff}}$ over a time $t$:\n$$\\langle x^{2} \\rangle = 2 D_{\\mathrm{eff}} t$$\n\nThe characteristic diffusion time, $t$, is the time required for a solute to traverse the slab of thickness $L$. In the context of diffusion, this time is estimated by setting the root-mean-square displacement, $\\sqrt{\\langle x^{2} \\rangle}$, equal to the characteristic distance, $L$. This gives the condition:\n$$\\langle x^{2} \\rangle = L^{2}$$\nSubstituting this condition into the mean-square displacement equation yields an expression for the characteristic time $t$:\n$$L^{2} = 2 D_{\\mathrm{eff}} t$$\nNow, we substitute the definition of $D_{\\mathrm{eff}}$ into this equation:\n$$L^{2} = 2 \\left(\\frac{D}{\\lambda^{2}}\\right) t$$\nWe solve this equation for $t$ to find its dependence on the other parameters, including $\\lambda$:\n$$t = \\frac{L^{2} \\lambda^{2}}{2 D}$$\nThis expression shows that the characteristic diffusion time $t$ is directly proportional to the square of the tortuosity, $\\lambda^{2}$, assuming $L$ and $D$ are constant. This is the derived dependence of $t$ on $\\lambda$.\n\nNext, we must find the multiplicative factor by which $t$ changes when $\\lambda$ increases. Let $t_{1}$ be the characteristic time corresponding to the initial tortuosity $\\lambda_{1}$, and $t_{2}$ be the time corresponding to the final tortuosity $\\lambda_{2}$.\nUsing the derived relation, we have:\n$$t_{1} = \\frac{L^{2} \\lambda_{1}^{2}}{2 D}$$\n$$t_{2} = \\frac{L^{2} \\lambda_{2}^{2}}{2 D}$$\nThe multiplicative factor is the ratio $\\frac{t_{2}}{t_{1}}$:\n$$\\frac{t_{2}}{t_{1}} = \\frac{\\left(\\frac{L^{2} \\lambda_{2}^{2}}{2 D}\\right)}{\\left(\\frac{L^{2} \\lambda_{1}^{2}}{2 D}\\right)}$$\nThe terms $L^{2}$, $2$, and $D$ are common to both the numerator and the denominator and thus cancel out, leaving:\n$$\\frac{t_{2}}{t_{1}} = \\frac{\\lambda_{2}^{2}}{\\lambda_{1}^{2}} = \\left(\\frac{\\lambda_{2}}{\\lambda_{1}}\\right)^{2}$$\nThe problem provides the numerical values for the initial and final tortuosities:\n$$\\lambda_{1} = 1.6$$\n$$\\lambda_{2} = 2.0$$\nSubstituting these values into the expression for the ratio:\n$$\\frac{t_{2}}{t_{1}} = \\left(\\frac{2.0}{1.6}\\right)^{2}$$\nWe compute the value of the ratio:\n$$\\frac{2.0}{1.6} = \\frac{20}{16} = \\frac{5}{4} = 1.25$$\nFinally, we square this value to obtain the multiplicative factor:\n$$\\left(1.25\\right)^{2} = \\left(\\frac{5}{4}\\right)^{2} = \\frac{25}{16} = 1.5625$$\nThis is the final dimensionless factor by which the diffusion time increases. The specific values for $L$ and $D$ are not required for this computation, as they cancel from the ratio.", "answer": "$$\\boxed{1.5625}$$", "id": "2744748"}, {"introduction": "The failure of axons to regrow through a glial scar is a major challenge in CNS repair, largely attributed to inhibitory molecules like CSPGs. This exercise applies the principles of probabilistic modeling to formalize this inhibition, treating axon extension as a \"survival\" process in a hazardous environment. You will derive the probability of an axon successfully traversing the scar from first principles and use this model to predict the therapeutic benefit of an enzyme that degrades CSPGs. [@problem_id:2744751]", "problem": "Reactive astrogliosis after central nervous system injury induces a dense extracellular matrix enriched in chondroitin sulfate proteoglycans (CSPGs), which inhibit axon elongation. Consider a neurite attempting to traverse a glial scar of thickness $\\ell$. Assume the following foundations, which reflect well-tested physical and biochemical principles applied to cell-scale transport in complex media: (i) encounters between the growing axon tip and inhibitory CSPG glycosaminoglycan chains are independent and memoryless along the path, (ii) the hazard of an encounter that irreversibly stalls extension is proportional to the local molar concentration of CSPG, denoted $c_{\\mathrm{CSPG}}$, and (iii) the proportionality constant per unit path length is $k$, which subsumes microscopic reaction and geometric factors. Let $P(x)$ denote the survival probability that the axon continues extending without being stalled after advancing a distance $x$ into the scar.\n\nStarting only from the above assumptions and the initial condition $P(0)=1$, derive the functional dependence of the net traversal probability $P$ on a spatially uniform CSPG concentration $c_{\\mathrm{CSPG}}$ across the scar, and show that it can be written in the form $P=\\exp(-\\alpha\\,c_{\\mathrm{CSPG}})$ for a suitable effective parameter $\\alpha$ that you should identify in terms of $k$ and $\\ell$.\n\nChondroitinase ABC (chABC) enzymatically cleaves the glycosaminoglycan chains on CSPGs and thereby reduces the effective inhibitory concentration within the scar. Suppose a treatment reduces $c_{\\mathrm{CSPG}}$ by a factor of $1/2$ from its pre-treatment value $c_{0}$, with all other parameters unchanged. Compute the absolute change in the traversal probability, $\\Delta P = P_{\\text{after}} - P_{\\text{before}}$, and express your final answer as a single closed-form expression in terms of $\\alpha$ and $c_{0}$. The final answer is dimensionless and requires no rounding.", "solution": "Let $P(x)$ be the probability that a neurite has successfully extended a distance $x$ into a glial scar of thickness $\\ell$ without being irreversibly stalled. We are given the initial condition $P(0) = 1$, which states that the probability of starting the extension is unity.\n\nThe problem states that the hazard of a stalling event is proportional to the local concentration of chondroitin sulfate proteoglycans (CSPGs), $c_{\\mathrm{CSPG}}$, with a proportionality constant per unit length of $k$. Since the encounters are independent and memoryless, this describes a Poisson process. The probability of a stalling event occurring within an infinitesimal interval of length $dx$ at position $x$, given that the neurite has survived up to $x$, is given by the hazard rate multiplied by the interval length. Let this probability be $p_{\\text{stall}}(dx)$.\n$$p_{\\text{stall}}(dx) = k \\cdot c_{\\mathrm{CSPG}} \\cdot dx$$\nThe concentration $c_{\\mathrm{CSPG}}$ is assumed to be spatially uniform throughout the scar.\n\nThe probability of the neurite surviving traversal of the interval $[x, x+dx]$, given it has survived to $x$, is $1 - p_{\\text{stall}}(dx) = 1 - k c_{\\mathrm{CSPG}} dx$.\n\nThe survival probability $P(x+dx)$ is the probability of having survived to $x$, which is $P(x)$, multiplied by the probability of surviving the next interval $[x, x+dx]$. Due to the memoryless nature of the process, these events are independent.\n$$P(x+dx) = P(x) \\cdot (1 - k c_{\\mathrm{CSPG}} dx)$$\nRearranging this equation, we get:\n$$P(x+dx) - P(x) = -k c_{\\mathrm{CSPG}} P(x) dx$$\nDividing by $dx$ and taking the limit as $dx \\to 0$ gives the definition of the derivative:\n$$\\frac{dP(x)}{dx} = \\lim_{dx \\to 0} \\frac{P(x+dx) - P(x)}{dx} = -k c_{\\mathrm{CSPG}} P(x)$$\nThis is a first-order separable ordinary differential equation. We can write it as:\n$$\\frac{dP}{P} = -k c_{\\mathrm{CSPG}} dx$$\nWe integrate this equation from the start of the scar at $x=0$ to an arbitrary distance $x'$ within the scar. The corresponding probabilities are $P(0)$ and $P(x')$.\n$$\\int_{P(0)}^{P(x')} \\frac{dP}{P} = \\int_{0}^{x'} -k c_{\\mathrm{CSPG}} dx$$\nSince $k$ and $c_{\\mathrm{CSPG}}$ are constants with respect to $x$, the integration yields:\n$$[\\ln P]_{P(0)}^{P(x')} = -k c_{\\mathrm{CSPG}} [x]_{0}^{x'}$$\n$$\\ln(P(x')) - \\ln(P(0)) = -k c_{\\mathrm{CSPG}} x'$$\nUsing the initial condition $P(0) = 1$, we have $\\ln(P(0)) = \\ln(1) = 0$.\n$$\\ln(P(x')) = -k c_{\\mathrm{CSPG}} x'$$\nExponentiating both sides gives the survival probability as a function of distance $x'$:\n$$P(x') = \\exp(-k c_{\\mathrm{CSPG}} x')$$\nThe net traversal probability, which we denote as $P$, is the probability of successfully traversing the entire scar of thickness $\\ell$. This is found by evaluating $P(x)$ at $x=\\ell$.\n$$P = P(\\ell) = \\exp(-k \\ell c_{\\mathrm{CSPG}})$$\nThe problem statement asserts that this probability can be written in the form $P = \\exp(-\\alpha c_{\\mathrm{CSPG}})$. By comparing our derived expression with this form, we can directly identify the effective parameter $\\alpha$.\n$$\\exp(-k \\ell c_{\\mathrm{CSPG}}) = \\exp(-\\alpha c_{\\mathrm{CSPG}})$$\nTherefore, the parameter $\\alpha$ is given by the product of the inhibitory constant per unit length and the scar thickness:\n$$\\alpha = k \\ell$$\n\nNext, we analyze the effect of a treatment with chondroitinase ABC. The pre-treatment CSPG concentration is $c_{0}$. The traversal probability before treatment, $P_{\\text{before}}$, is:\n$$P_{\\text{before}} = \\exp(-\\alpha c_{0})$$\nThe treatment reduces the concentration by a factor of $1/2$, so the post-treatment concentration is $c_{0}/2$. The traversal probability after treatment, $P_{\\text{after}}$, is:\n$$P_{\\text{after}} = \\exp\\left(-\\alpha \\frac{c_{0}}{2}\\right)$$\nThe problem asks for the absolute change in traversal probability, $\\Delta P = P_{\\text{after}} - P_{\\text{before}}$. Substituting the expressions for the probabilities, we obtain:\n$$\\Delta P = \\exp\\left(-\\frac{\\alpha c_{0}}{2}\\right) - \\exp(-\\alpha c_{0})$$\nThis is the final expression for the change in traversal probability in terms of $\\alpha$ and $c_{0}$.", "answer": "$$\\boxed{\\exp\\left(-\\frac{\\alpha c_{0}}{2}\\right) - \\exp(-\\alpha c_{0})}$$", "id": "2744751"}]}